Matt Holian

“Matt Holian is a leading strategist in complex, multi-jurisdictional product liability and related lawsuits, particularly federal multi-district litigation (MDL), Matt’s MDL cases primarily involve the pharmaceutical, medical device, and chemical industries. He also has litigated cases involving the False Claims Act, consumer fraud, and commercial disputes relating to licensing agreements.

Matt also has an active regulatory and enforcement practice, which includes conducting compliance investigations, counseling clients regarding research and development issues (including defending hundreds of claims asserted by patients in clinical trials) and advising life sciences and other clients on a wide range of emerging regulatory issues, such as product labeling, First Amendment challenges to promotional restrictions, real word evidence and value-based contracts.

Representative cases:

• In re Zantac (Ranitidine) Products Liability Litigation, MDL 2924 (SD. Fla.): Serve as co-national counsel for Sanofi
• In re Aqueous Film-Forming Foams Products Liability Litigation, MDL 2873 (D.S.C.): Serve as national counsel for BASF
• In re Chantix (Varenicline) Marketing, Sales Practices, & Products Liability Litigation (II), MDL 3050 (S.D.N.Y.): Serve as co-national counsel for Pfizer
• In re Viagra (Sildenafil Citrate) and Cialis (Tadalafil) Products Liability Litigation, MDL 2691 (N.D. Cal.): Co-national counsel for Pfizer
• In re Eliquis Products Liability Litigation, MDL 2754 (S.D.N.Y.): National counsel for Bristol-Myers Squibb Co. and Pfizer
• In re Proton Pump Inhibitor Products Liability Litigation, MDL 2789 (D.N.J.): National counsel for Pfizer and Wyeth
• Talc Product Liability Litigation: National counsel for BASF Catalysts LLC in nationwide litigation involving personal injuries allegedly caused by talc
• Tecfidera Litigation: Counsel for Biogen in personal injury suits involving MS medication
• In re Testosterone Replacement Therapy Products Liability Litigation, MDL 2545 (N.D. Ill.): National counsel for Pfizer and Pharmacia & Upjohn
• In re Chantix (Varenicline) Products Liability Litigation, MDL 2092 (N.D. Ala.): Appointed by MDL court as Defendants’ Liaison Counsel
• Pepe v. Genzyme Corporation et al. (D. Mass.): Represented Genzyme
• In re Prempro Products Liability Litigation, 738 F. Supp. 2d 887 (E.D. Ark. 2010):
• In re Bextra and Celebrex Marketing, Sales Practices and Products Liability Litigation,MDL No. 1699 (N.D. Cal.): Defended Pfizer
• Represented Pfizer in securities class action
• Baycol Litigation: Defended Bayer
• Buckingham v. Bayer Corporation (San Diego Superior Court): Obtained dismissal with prejudice of putative consumer fraud litigation against Bayer

Education:

• J.D., Stanford University 2000, Order of the Coif; Teaching Assistant, Federal Litigation; Associate Editor, Stanford Law Review; Senior Editor, Stanford Law and Policy Review; Co-President, Stanford Law Students Association. B.A., Harvard University 1995, Social Studies; Truman Scholar; magna cum laude